Wolfgang Miesbach – ASH 2025: What’s Coming in Bleeding and Thrombosis?
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
”By The Numbers
– 8,200 abstracts (record-breaking)
– 650-980 hemostasis-focused presentations across 8 categories
– 50 Sanofi abstracts | 46 Roche | 25+ Takeda contributions
– 6 late-breaking abstracts drop December 1 + 6 plenary abstracts
Haemophilia: Game-Changing Therapies
– Next-Gen Bispecific Antibodies
– Gene Therapy Updates
– RNA Silencing
Platelet Disorders: ITP Innovation
Rilzabrutinib (WAYRILZ) – First BTK inhibitor for ITP
– 65% platelet response vs 33% placebo
– 23% durable response vs 0% placebo
– Reduced bleeding + improved quality of life
– Plus: New data on rilzabrutinib in warm autoimmune hemolytic anemia (wAIHA) and sickle cell disease
Thrombosis: A Major Shift
NEW 2025 ASH/ISTH Pediatric VTE Guidelines
DOACs (rivaroxaban, dabigatran) now preferred over standard care (LMWH/warfarin) for kids with VTE. Oral anticoagulation changing the game.
Novel Thrombolytic Therapy
TargED Biopharmaceuticals’ TGD001 – first-in-human data on VWF-targeting thrombolytic for stroke, PE, and thrombotic thrombocytopenic purpura
Von Willebrand Disease
– VONVENDI Phase 3 pediatric data (supported Sept 2025 FDA approval)
– VGA039 – novel Protein S-targeting antibody with Phase 1/2 multidose results”
Stay updated with Hemostasis Today.
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25
-
Jan 7, 2026, 05:04Heghine Khachatryan on VWD: A Landmark in the History of Hematology
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications